RBM47 and neoplasm: RBM47 has also been recognized as a posttranscriptional regulator of epithelial cell-specific alternative splicing events and as a modulator of mRNA stability for key Wnt/β-catenin signaling antagonists, through which it exerts tumor-suppressive effects [33].